文献速递免疫规划卫生政策与健康促进

2020至2022年全球2019冠状病毒病疫苗犹豫的时空分布:一项Meta分析

Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis.
PubMed 文献 · Vaccine · 2025-03-03

该Meta分析纳入855项研究、共277285178名参与者,评估2020至2022年全球COVID-19疫苗犹豫率。符合定义1的研究中犹豫率逐年上升(2020年18.8%、2021年29.1%、2022年30.8%),符合定义2的研究中犹豫率维持在35%;非洲研究犹豫率最高(42.0%),欧洲最低(16.5%)。

要点

  • 符合定义1的研究中,COVID-19疫苗犹豫率从2020年18.8%升至2021年29.1%、2022年30.8%。
  • 符合定义2的研究中,疫苗犹豫率维持在35%。
  • 非洲研究报告的犹豫率最高(42.0%),欧洲研究最低(16.5%)。

核心结论

  • 2020至2022年间COVID-19疫苗犹豫率上升,可能受错误信息、政策变化和公众疲劳影响。
  • 年龄、性别和教育等人口学因素在疫苗犹豫中起关键作用。
  • 疫苗犹豫与疫情严重程度的关联凸显及时有效公共卫生应对的必要性。

研究设计与样本

  • 检索PubMed、Web of Science和Embase数据库中2020年1月至2023年12月发表的英文研究。
  • 纳入横断面和队列研究,研究人群为≥18岁普通成年人群,并提供COVID-19疫苗接受或犹豫的定量数据。
  • 采用随机效应模型进行Meta分析,最终分析数据集纳入855项研究,其中121项符合定义1、734项符合定义2。
  • 纳入研究的参与者共277285178名。

主要发现

  • 符合定义1的研究中,犹豫率逐年上升:2020年18.8%、2021年29.1%、2022年30.8%。
  • 符合定义2的研究中,犹豫率维持在35%。
  • 非洲研究报告的犹豫率全球最高(42.0%),欧洲研究报告最低(16.5%)。
  • 月度累计死亡峰值与较低的犹豫峰值在时间上重合。

关键数值与推荐

  • 定义1结合疫苗接种行为和意愿,定义2仅基于接种意愿。
  • 符合定义1的研究中犹豫率:2020年18.8%、2021年29.1%、2022年30.8%。
  • 符合定义2的研究中犹豫率维持在35%。
  • 非洲研究犹豫率42.0%,欧洲研究犹豫率16.5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Vaccine hesitancy is a major barrier to high coronavirus disease 2019 (COVID-19) vaccine coverage. To synthesize global research on COVID-19 vaccine hesitancy, a meta-analysis was conducted to provide scientific evidence for understanding its spatial and temporal variations and influencing factors. METHODS: We searched the PubMed, Web of Science, and Embase databases for studies published in English between January 2020 and December 2023 and included cross-sectional and cohort studies with study populations that included the general adult population aged ≥18 years and provided quantitative data on COVID-19 vaccine acceptance or hesitancy. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis elements and guidance for abstracting and assessing data quality and validity. Two groups of investigators independently extracted the study characteristics, including the outcome variable (the vaccine hesitancy rate). Our meta-analysis used a random-effects model. The outcome of interest was COVID-19 vaccine hesitancy. The included studies were divided into two categories based on their definitions of COVID-19 vaccine hesitancy. Definition 1 combined vaccination behavior and willingness, and Definition 2 was based solely on willingness to vaccinate. RESULTS: 855 studies were included in the final analytical dataset; 121 met Definition 1, and 734 met Definition 2. There were 277,285,178 participants in the included studies. In studies meeting Definition 1, hesitancy rates increased annually: 18.8 % in 2020, 29.1 % in 2021, and 30.8 % in 2022. However, in studies that met Definition 2, the hesitancy rates remained at 35 %. African studies reported the highest hesitancy rates globally (42.0 %), whereas European studies reported the lowest (16.5 %). Furthermore, there was a temporal association between mortality trends and COVID-19 hesitancy because the monthly cumulative death peaks coincided with lower hesitancy peaks. CONCLUSION: COVID-19 vaccine hesitancy increased across the continent during 2020-2022 and might be influenced by misinformation, policy changes, and public fatigue. Demographic factors like age, gender, and education also play a key role in vaccine hesitancy. The link between vaccine hesitancy and pandemic severity highlights the need for timely and effective public health responses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhao T, Xu Q, Cai X, et al. Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis. Vaccine. 2025. PMID: 40037126. doi:10.1016/j.vaccine.2025.126933

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。